Four-weekly infliximab in the treatment of severe hidradenitis suppurativa

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

(2013) Alexa B. Kimball et al.   ANNALS OF INTERNAL MEDICINE

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

(2012) Gerd R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

Interstitial Keratitis Secondary to Severe Hidradenitis Suppurativa: A Case Report and Literature Review

(2010) Ana G Alzaga Fernandez et al.   CORNEA

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

(2010) Annika Grant et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry

(2009) X Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

(2009) C.H. Smith et al.   BRITISH JOURNAL OF DERMATOLOGY